Pneumococcal Conjugate Vaccine (V114)

Pneumococcal Conjugate Vaccine · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pneumococcal Conjugate Vaccine (V114), covering 2019-04-30 to 2019-04-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003) [Phase 2]